Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association

Saverio Ladogana, Matteo Maruzzi, Piera Samperi, Silverio Perrotta, Giovanni C. Del Vecchio, Lucia D. Notarangelo, Piero Farruggia, Federico Verzegnassi, Nicoletta Masera, Paola Saracco, Silvia Fasoli, Maurizio Miano, Gabriella Girelli, Wilma Barcellini, Alberto Zanella, Giovanna Russo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Autoimmune haemolytic anaemia is an uncommon disorder to which paediatric haematology centres take a variety of diagnostic and therapeutic approaches. The Red Cell Working Group of the Italian Association of Paediatric Onco-haematology (Associazione Italiana di Ematologia ed Oncologia Pediatrica, AIEOP) developed this document in order to collate expert opinions on the management of newly diagnosed childhood autoimmune haemolytic anaemia. The diagnostic process includes the direct and indirect antiglobulin tests; recommendations are given regarding further diagnostic tests, specifically in the cases that the direct and indirect antiglobulin tests are negative. Clear-cut definitions of clinical response are stated. Specific recommendations for treatment include: dosage of steroid therapy and tapering modality for warm autoimmune haemolytic anaemia; the choice of rituximab as first-line therapy for the rare primary transfusion-dependent cold autoimmune haemolytic anaemia; the indications for supportive therapy; the need for switching to second-line therapy. Each statement is provided with a score expressing the level of appropriateness and the agreement among participants.

Original languageEnglish
Pages (from-to)259-267
Number of pages9
JournalBlood Transfusion
Volume15
Issue number3
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Autoimmune Hemolytic Anemia
Coombs Test
Pediatrics
Hematology
Therapeutics
Expert Testimony
Routine Diagnostic Tests
Steroids

Keywords

  • Autoimmune haemolytic anaemia
  • Child
  • DAT
  • Diagnosis therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Hematology

Cite this

Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association. / Ladogana, Saverio; Maruzzi, Matteo; Samperi, Piera; Perrotta, Silverio; Del Vecchio, Giovanni C.; Notarangelo, Lucia D.; Farruggia, Piero; Verzegnassi, Federico; Masera, Nicoletta; Saracco, Paola; Fasoli, Silvia; Miano, Maurizio; Girelli, Gabriella; Barcellini, Wilma; Zanella, Alberto; Russo, Giovanna.

In: Blood Transfusion, Vol. 15, No. 3, 01.05.2017, p. 259-267.

Research output: Contribution to journalArticle

Ladogana, S, Maruzzi, M, Samperi, P, Perrotta, S, Del Vecchio, GC, Notarangelo, LD, Farruggia, P, Verzegnassi, F, Masera, N, Saracco, P, Fasoli, S, Miano, M, Girelli, G, Barcellini, W, Zanella, A & Russo, G 2017, 'Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association', Blood Transfusion, vol. 15, no. 3, pp. 259-267. https://doi.org/10.2450/2016.0072-16
Ladogana, Saverio ; Maruzzi, Matteo ; Samperi, Piera ; Perrotta, Silverio ; Del Vecchio, Giovanni C. ; Notarangelo, Lucia D. ; Farruggia, Piero ; Verzegnassi, Federico ; Masera, Nicoletta ; Saracco, Paola ; Fasoli, Silvia ; Miano, Maurizio ; Girelli, Gabriella ; Barcellini, Wilma ; Zanella, Alberto ; Russo, Giovanna. / Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association. In: Blood Transfusion. 2017 ; Vol. 15, No. 3. pp. 259-267.
@article{faeb7cd5e48945fbb223ea1832318068,
title = "Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association",
abstract = "Autoimmune haemolytic anaemia is an uncommon disorder to which paediatric haematology centres take a variety of diagnostic and therapeutic approaches. The Red Cell Working Group of the Italian Association of Paediatric Onco-haematology (Associazione Italiana di Ematologia ed Oncologia Pediatrica, AIEOP) developed this document in order to collate expert opinions on the management of newly diagnosed childhood autoimmune haemolytic anaemia. The diagnostic process includes the direct and indirect antiglobulin tests; recommendations are given regarding further diagnostic tests, specifically in the cases that the direct and indirect antiglobulin tests are negative. Clear-cut definitions of clinical response are stated. Specific recommendations for treatment include: dosage of steroid therapy and tapering modality for warm autoimmune haemolytic anaemia; the choice of rituximab as first-line therapy for the rare primary transfusion-dependent cold autoimmune haemolytic anaemia; the indications for supportive therapy; the need for switching to second-line therapy. Each statement is provided with a score expressing the level of appropriateness and the agreement among participants.",
keywords = "Autoimmune haemolytic anaemia, Child, DAT, Diagnosis therapy",
author = "Saverio Ladogana and Matteo Maruzzi and Piera Samperi and Silverio Perrotta and {Del Vecchio}, {Giovanni C.} and Notarangelo, {Lucia D.} and Piero Farruggia and Federico Verzegnassi and Nicoletta Masera and Paola Saracco and Silvia Fasoli and Maurizio Miano and Gabriella Girelli and Wilma Barcellini and Alberto Zanella and Giovanna Russo",
year = "2017",
month = "5",
day = "1",
doi = "10.2450/2016.0072-16",
language = "English",
volume = "15",
pages = "259--267",
journal = "Blood Transfusion",
issn = "1723-2007",
publisher = "Edizioni SIMTI",
number = "3",

}

TY - JOUR

T1 - Diagnosis & management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the red cell study group of the paediatric haemato-oncology Italian association

AU - Ladogana, Saverio

AU - Maruzzi, Matteo

AU - Samperi, Piera

AU - Perrotta, Silverio

AU - Del Vecchio, Giovanni C.

AU - Notarangelo, Lucia D.

AU - Farruggia, Piero

AU - Verzegnassi, Federico

AU - Masera, Nicoletta

AU - Saracco, Paola

AU - Fasoli, Silvia

AU - Miano, Maurizio

AU - Girelli, Gabriella

AU - Barcellini, Wilma

AU - Zanella, Alberto

AU - Russo, Giovanna

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Autoimmune haemolytic anaemia is an uncommon disorder to which paediatric haematology centres take a variety of diagnostic and therapeutic approaches. The Red Cell Working Group of the Italian Association of Paediatric Onco-haematology (Associazione Italiana di Ematologia ed Oncologia Pediatrica, AIEOP) developed this document in order to collate expert opinions on the management of newly diagnosed childhood autoimmune haemolytic anaemia. The diagnostic process includes the direct and indirect antiglobulin tests; recommendations are given regarding further diagnostic tests, specifically in the cases that the direct and indirect antiglobulin tests are negative. Clear-cut definitions of clinical response are stated. Specific recommendations for treatment include: dosage of steroid therapy and tapering modality for warm autoimmune haemolytic anaemia; the choice of rituximab as first-line therapy for the rare primary transfusion-dependent cold autoimmune haemolytic anaemia; the indications for supportive therapy; the need for switching to second-line therapy. Each statement is provided with a score expressing the level of appropriateness and the agreement among participants.

AB - Autoimmune haemolytic anaemia is an uncommon disorder to which paediatric haematology centres take a variety of diagnostic and therapeutic approaches. The Red Cell Working Group of the Italian Association of Paediatric Onco-haematology (Associazione Italiana di Ematologia ed Oncologia Pediatrica, AIEOP) developed this document in order to collate expert opinions on the management of newly diagnosed childhood autoimmune haemolytic anaemia. The diagnostic process includes the direct and indirect antiglobulin tests; recommendations are given regarding further diagnostic tests, specifically in the cases that the direct and indirect antiglobulin tests are negative. Clear-cut definitions of clinical response are stated. Specific recommendations for treatment include: dosage of steroid therapy and tapering modality for warm autoimmune haemolytic anaemia; the choice of rituximab as first-line therapy for the rare primary transfusion-dependent cold autoimmune haemolytic anaemia; the indications for supportive therapy; the need for switching to second-line therapy. Each statement is provided with a score expressing the level of appropriateness and the agreement among participants.

KW - Autoimmune haemolytic anaemia

KW - Child

KW - DAT

KW - Diagnosis therapy

UR - http://www.scopus.com/inward/record.url?scp=85020096359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020096359&partnerID=8YFLogxK

U2 - 10.2450/2016.0072-16

DO - 10.2450/2016.0072-16

M3 - Article

AN - SCOPUS:85020096359

VL - 15

SP - 259

EP - 267

JO - Blood Transfusion

JF - Blood Transfusion

SN - 1723-2007

IS - 3

ER -